PHARMACOGENETICS OF VINORELBINE IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS
Latest Information Update: 12 Sep 2022
At a glance
- Drugs Vinorelbine (Primary) ; Vinorelbine (Primary)
- Indications Malignant-mesothelioma
- Focus Pharmacodynamics; Pharmacogenomic
- 08 Sep 2022 Status changed from active, no longer recruiting to completed.
- 09 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 09 Feb 2017 Status changed from recruiting to active, no longer recruiting.